Stockscreener 앱 받기
391.27
1.64%
-6.53
시간 외 거래:
393.27
2.00
+0.51%
전일 마감가:
$397.80
열려 있는:
$395.68
하루 거래량:
1.28M
Relative Volume:
0.75
시가총액:
$84.97B
수익:
$200.42B
순이익/손실:
$5.24B
주가수익비율:
16.65
EPS:
23.5042
순현금흐름:
$6.45B
1주 성능:
-3.29%
1개월 성능:
-0.36%
6개월 성능:
+13.10%
1년 성능:
+4.29%
1일 변동 폭
$388.00
$396.89
1주일 범위
$388.00
$406.92
52주 변동 폭
$273.71
$426.98
엘리번스 헬스 Stock (ELV) Company Profile
명칭
Elevance Health Inc
전화
(800) 331-1476
주소
220 VIRGINIA AVENUE, INDIANAPOLIS
Compare ELV vs UNH, CVS, CI, HUM
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ELV
Elevance Health Inc
|
391.27 | 87.28B | 200.42B | 5.24B | 6.45B | 23.50 |
UNH
Unitedhealth Group Inc
|
399.53 | 373.28B | 449.71B | 12.81B | 19.67B | 13.24 |
CVS
Cvs Health Corp
|
99.16 | 128.46B | 407.94B | 2.90B | 7.39B | 2.2771 |
CI
Cigna Group
|
285.09 | 77.73B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
362.00 | 45.65B | 137.20B | 1.15B | 1.27B | 9.3439 |
엘리번스 헬스 Stock (ELV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-08 | 개시 | Evercore ISI | In-line |
| 2026-02-03 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2026-01-08 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2025-12-19 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2025-10-14 | 개시 | Goldman | Neutral |
| 2025-07-21 | 다운그레이드 | Argus | Buy → Hold |
| 2025-07-18 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2025-04-15 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2025-03-17 | 업그레이드 | Argus | Hold → Buy |
| 2025-01-22 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2024-10-18 | 다운그레이드 | Argus | Buy → Hold |
| 2024-07-18 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2024-06-24 | 개시 | Morgan Stanley | Overweight |
| 2024-05-30 | 개시 | Robert W. Baird | Outperform |
| 2024-03-06 | 개시 | Barclays | Overweight |
| 2023-07-12 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2023-04-27 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-21 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-03-28 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-09-09 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-08-22 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
모두보기
엘리번스 헬스 주식(ELV)의 최신 뉴스
Insider Sell: Ronald Penczek Sells Shares of Elevance Health Inc (ELV) - GuruFocus
Elevance Health (ELV) CAO sells 369 shares in open-market trade - Stock Titan
Elevance Health Introduces Total Movement Care and Enhances Chronic Care Support with Connected, Personalized Services - marketscreener.com
Elevance Health Makes Chronic Care Easier to Navigate With Connected, Personalized Support - Business Wire
Elevance Health Inc Stock (US0367521038): Stock in focus after a quiet Monday setup - AD HOC NEWS
Insider Sell: Dixon Robert L JR Sells Shares of Elevance Health Inc (ELV) - GuruFocus
Form 144: Ronald Penczek sale of 1,531 ELV shares (ELV) - Stock Titan
Elevance Health Inc. stock outperforms competitors on strong trading day - MarketWatch
Elevance Health (ELV) director reports open-market sale of common stock - Stock Titan
Elevance Health (ELV) Stock Price, News & Analysis $ELV - MarketBeat
Elevance Health, Inc. (ELV) Latest Stock News & Headlines - Yahoo Finance
[144] Elevance Health, Inc. SEC Filing - Stock Titan
Elevance Health Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Morgan Stanley (MS) issues 300% leveraged PLUS tied to Elevance Health (ELV) stock - Stock Titan
Elevance Health Inc (ELV) Shares Fall 4.7% -- What GF Score of 9 - GuruFocus
Elevance Health Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Elevance Health Inc Stock (ELV) Moved Down by 5.03% on Jun 10: Facts Behind the Movement - TradingKey
Elevance Health (ELV) Reaffirms 2026 Earnings and Expense Guidan - GuruFocus
Elevance Health (ELV) slides as investors refocus on CMS compliance overhang ahead of key late-June deadline - Quiver Quantitative
Elevance Health Inc at Goldman Sachs Healthcare Conference Transcript - GuruFocus
Elevance Health Reaffirms 2026 Adjusted EPS Guidance - marketscreener.com
(ELV) Elevance Health Expects 2026 Adjusted EPS At Least $26.75, vs. FactSet Est of $26.85 - marketscreener.com
Elevance Health (NYSE: ELV) reiterates 2026 EPS and benefit ratio outlook - Stock Titan
Elevance Health stock: Is ELV underperforming the health care sector? - MSN
Elevance Health Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Elevance files lawsuit against former executive for noncompete violation - The Indiana Lawyer
Morgan Stanley (MS) launches 1‑year 300%‑leveraged PLUS on ELV with $1,370.50 cap - Stock Titan
Elevance Health stock hits 52-week high at 422.65 USD By Investing.com - Investing.com Nigeria
Elevance Health stock hits 52-week high at 422.65 USD - Investing.com
Are Wall Street analysts predicting Elevance stock will climb or sink? - MSN
JPMorgan Adjusts Price Target on Elevance Health to $476 From $411, Maintains Overweight Rating - marketscreener.com
ELV Stock Quote Price and Forecast - CNN
Medicare Advantage in 2026: Enrollment Update and Key Trends - KFF
Q1 Earnings Outperformers: Elevance Health (NYSE:ELV) And The Rest Of The Health Insurance Providers Stocks - Yahoo Finance
UnitedHealth Stock Jumps 20% YTD: Should Investors Jump in Too? - TradingView
Analysts Are Bullish on Top Healthcare Stocks: Elevance Health (ELV), Indivior (INDV) - The Globe and Mail
Elevance Health Inc (ELV) Stock Price, Trades & News - GuruFocus
How Investors Are Reacting To Elevance Health (ELV) Expanding Digital Access For Underserved Patients - simplywall.st
Elevance Health, Inc. Stock 12‑Month Price Target Raised to $406.38, Implies 4% Upside - TradingView
UnitedHealth Prescribes Another Dividend Increase: Just a Lighter Dose - TradingView
Elevance Health, Inc. Stock 12‑Month Price Target Raised to $405.19, Implies 4% Upside - TradingView
Chutes & Ladders—Ardent Health appoints new CEO; KFF Founding President, CEO to retire - Fierce Healthcare
Elevance Health’s Digital Equity Push Reframes Virtual Care And Investor Narrative - Yahoo Finance
Collis buys Elevance Health (ELV) shares worth $869,519 By Investing.com - Investing.com Nigeria
Elevance Health Inc (ELV) Shares Fall 3.4% -- What GF Score of 8 - GuruFocus
Elevance Health Inc (ELV) Shares Fall 3.4% -- What GF Score of 89 Tells Investors - GuruFocus
Elevance Health Outperforms Sector Market in Early 2026 - asatunews.co.id
Elevance Health Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Collis buys Elevance Health (ELV) shares worth $869,519 - Investing.com
Elevance Health Price Target Raised to $450.00/Share From $375.00 by Truist Securities - Moomoo
Elevance again avoids Medicare Advantage sanctions, but threat remains - Healthcare Dive
엘리번스 헬스 (ELV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.33%
자본화:
|
볼륨(24시간):